BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34895310)

  • 21. Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations.
    McInnes IB; Byers NL; Higgs RE; Lee J; Macias WL; Na S; Ortmann RA; Rocha G; Rooney TP; Wehrman T; Zhang X; Zuckerman SH; Taylor PC
    Arthritis Res Ther; 2019 Aug; 21(1):183. PubMed ID: 31375130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib.
    Traves PG; Murray B; Campigotto F; Galien R; Meng A; Di Paolo JA
    Ann Rheum Dis; 2021 Jul; 80(7):865-875. PubMed ID: 33741556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state.
    Briscoe J; Rogers NC; Witthuhn BA; Watling D; Harpur AG; Wilks AF; Stark GR; Ihle JN; Kerr IM
    EMBO J; 1996 Feb; 15(4):799-809. PubMed ID: 8631301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liraglutide Exerts Potential Anti-inflammatory Effect in Type 1 Diabetes by Inhibiting IFN-γ Production
    Zhao Y; Xie Y; Li W
    Endocr Metab Immune Disord Drug Targets; 2019; 19(5):656-664. PubMed ID: 30827273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-γ stimulates human follicular dendritic cell-like cells to produce prostaglandins via the JAK-STAT pathway.
    Kim J; Yoon Y; Jeoung D; Kim YM; Choe J
    Mol Immunol; 2015 Aug; 66(2):189-96. PubMed ID: 25818476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoliquiritigenin Inhibits Interferon-γ-Inducible Genes Expression in Hepatocytes through Down-Regulating Activation of JAK1/STAT1, IRF3/MyD88, ERK/MAPK, JNK/MAPK and PI3K/Akt Signaling Pathways.
    Wu S; Xue J; Yang Y; Zhu H; Chen F; Wang J; Lou G; Liu Y; Shi Y; Yu Y; Xia C; Hu Y; Chen Z
    Cell Physiol Biochem; 2015; 37(2):501-14. PubMed ID: 26315837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.
    Gallmeier E; Schäfer C; Moubarak P; Tietz A; Plössl I; Huss R; Göke B; Wagner AC
    J Cell Physiol; 2005 Apr; 203(1):209-16. PubMed ID: 15493010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
    Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
    Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors.
    Sakatsume M; Igarashi K; Winestock KD; Garotta G; Larner AC; Finbloom DS
    J Biol Chem; 1995 Jul; 270(29):17528-34. PubMed ID: 7615558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on alleviating neuroinflammatory injury in ischemic stroke rats by electrical stimulation with scalp acupuncture based on IFN-γ mediated JAK/STAT1 signaling pathway].
    Peng XY; Yuan B; Li XL; Bao YC; Luo WJ; Zhang YJ; Zhao M; Wang JH
    Zhen Ci Yan Jiu; 2023 Sep; 48(9):852-9. PubMed ID: 37730255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Jak-STAT pathway stimulated by interferon gamma.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr8. PubMed ID: 15561980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-4-mediated inhibition of nitric oxide production in interferon-gamma-treated and virus-infected macrophages.
    Paludan SR; Ellermann-Eriksen S; Lovmand J; Mogensen SC
    Scand J Immunol; 1999 Feb; 49(2):169-76. PubMed ID: 10075021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
    Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
    J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFN-γ-induced IL-27 and IL-27p28 expression are differentially regulated through JNK MAPK and PI3K pathways independent of Jak/STAT in human monocytic cells.
    Blahoianu MA; Rahimi AA; Kozlowski M; Angel JB; Kumar A
    Immunobiology; 2014 Jan; 219(1):1-8. PubMed ID: 23891538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma enhances superoxide production in human mesangial cells via the JAK-STAT pathway.
    Moriwaki K; Kiyomoto H; Hitomi H; Ihara G; Kaifu K; Matsubara K; Hara T; Kondo N; Ohmori K; Nishiyama A; Fukui T; Kohno M
    Kidney Int; 2006 Aug; 70(4):788-93. PubMed ID: 16820786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes.
    Joyo Y; Kawaguchi Y; Yonezu H; Senda H; Yasuma S; Shiraga H; Nozaki M; Aoyama M; Asai K; Murakami H; Waguri-Nagaya Y
    Immunol Res; 2022 Apr; 70(2):208-215. PubMed ID: 35014010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
    Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
    J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.